Belavit AD3E, solution for injection for horses, cattle, pigs, and dogs
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
06-01-2022
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
Retinol palmitate ; dl-alpha tocopherol acetate; Colecalciferol concentrate (oily form)
Inapatikana kutoka:
Bela-Pharm GmbH & Co. KG
ATC kanuni:
QA11JA
INN (Jina la Kimataifa):
Retinol palmitate ; dl-alpha tocopherol acetate; Colecalciferol concentrate (oily form)
Kipimo:
176.47,50.00,100.00 milligram(s)/millilitre
Dawa fomu:
Solution for injection
Dawa ya aina:
LM: Licensed Merchant as defined in relevant national legislation
Eneo la matibabu:
Combinations of vitamins
Idhini hali ya:
Authorised
Idhini ya tarehe:
2019-07-26
Tabia za bidhaa
Health Products Regulatory Authority
05 January 2022
CRN00CMKP
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Belavit AD3E, solution for injection for horses, cattle, pigs, and
dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml solution for injection contains
ACTIVE SUBSTANCE:
Retinol palmitate
176.47
mg
(equivalent to 300,000 I.U. Vitamin A)
all-rac alpha tocopheryl acetate
50.00
mg
(equivalent to 45.56 mg alpha-tocopherol)
(Vitamin E)
Oily solution of cholecalciferol
100.00
mg
(contains 2.5 mg cholecalciferol; equivalent to 100,000 I.U. Vitamin D
3
)
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection
Clear, yellow solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horses, pigs and dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of combined vitamin A, vitamin D, and vitamin E
deficiencies.
4.3 CONTRAINDICATIONS
Do not use in food producing animals with adequate vitamin A supply
due to the possibility of accumulation in edible tissues.
The treatment with Vitamin AD
3
E is contraindicated in case of a hypervitaminosis.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
The recommended dose and duration of treatment should not be exceeded.
The use of intramuscular lipid-soluble vitamin products in horses may
increase the risk of myositis and myonecrosis.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
- In case of accidental self-injection, a risk of hypervitaminosis in
relation to vitamin A cannot be excluded. Therefore,
administration should be performed with great caution. In case of
accidental self-injection, seek medical advice immedia
Soma hati kamili
